Dec 31, 2021

Carlisle Q4 2021 Earnings Report

Carlisle reported record revenues, adjusted EBITDA, and adjusted diluted EPS, driven by proactive pricing and strong demand.

Key Takeaways

Carlisle Companies reported record fourth-quarter results, with revenues of $1.4 billion, a 39.2% increase year-over-year. Organic revenue increased by 26.4%. GAAP Diluted EPS was $2.46, and Adjusted Diluted EPS was $2.92, a 60% increase from the prior year. The company's performance was driven by strong demand, proactive pricing actions, and the successful integration of the Henry acquisition.

Generated record fourth quarter revenues of $1.4 billion, up 26.4% organically year-over-year

CCM delivered record revenues and profitability despite supply chain disruptions and with proactive pricing actions offsetting inflation

Reported record fourth quarter GAAP Diluted EPS of $2.46 and Adjusted Diluted EPS of $2.92, a 60% increase from prior year

Henry integration exceeding expectations with synergies tracking above original $30 million target, driving Adjusted Diluted EPS accretion of $1.50+ in 2022, up from $1.25 in original plan

Total Revenue
$1.38B
Previous year: $1.06B
+29.3%
EPS
$2.92
Previous year: $1.57
+86.0%
Organic Revenue Growth
26.4%
Previous year: -9%
-393.3%
Gross Profit
$391M
Previous year: $293M
+33.5%
Cash and Equivalents
$324M
Previous year: $902M
-64.0%
Free Cash Flow
$92.3M
Previous year: $234M
-60.5%
Total Assets
$2.93B
Previous year: $5.87B
-50.1%

Carlisle

Carlisle

Carlisle Revenue by Segment

Forward Guidance

While our businesses continue to navigate significant supply chain and inflationary challenges, solid demand fundamentals for all of our businesses remain intact.

Positive Outlook

  • a strong multi-year re-roofing cycle
  • positive new construction environment
  • continued pent up demand from pandemic-related challenges in 2020 and 2021
  • growing customer demand for energy-efficient products for the Building Envelope
  • increasing passenger air travel numbers and improved capital spending in Medical and Industrial markets, all of which are returning to pre-pandemic levels, and bode well for our CIT and CFT businesses

Challenges Ahead

  • significant supply chain challenges
  • inflationary challenges

Revenue & Expenses

Visualization of income flow from segment revenue to net income